Response Pharmaceuticals
PrivateLast Round
Series B
Apr 23, 2024
Total Funding Raised
$8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Response Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for weight management and metabolic health, with a lead candidate, RDX-002, being evaluated for antipsychotic-induced weight gain and post-GLP-1 weight management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Response Pharmaceuticals Comparables
Compare Response Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aardark Therapeutics | 74% | |
| EktaH | 71% | |
| Corcept Therapeutics Incorporated | 69% |
Response Pharmaceuticals Funding Rounds
Historical fundraising activity
Response Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Collage Venture Partners | Series A |
| Transhuman Capital | Series A |
| CrossWork | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 280% MoM, reaching 920.
Response Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Response Pharmaceuticals's valuation, stock price, and market status.
Is Response Pharmaceuticals a public or private company?
Response Pharmaceuticals is a private company.
What is the current stock price of Response Pharmaceuticals?
Response Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Response Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Response Pharmaceuticals worth (valuation)?
Valuation information for Response Pharmaceuticals is not publicly available.
Can I buy Response Pharmaceuticals stock?
Response Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Response Pharmaceuticals's last funding round?
Response Pharmaceuticals's most recent funding round was Series B on April 23, 2024.
Who are the main investors in Response Pharmaceuticals?
Key investors in Response Pharmaceuticals include Collage Venture Partners, Transhuman Capital, CrossWork.
Will Response Pharmaceuticals IPO soon?
No public IPO plans have been announced for Response Pharmaceuticals.
How can I track Response Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Response Pharmaceuticals's shares on secondary markets.